HYPD vs REGN · rev $57.3K vs P/E 14, rev $14.34B
Hyperion DeFi, Inc. (HYPD) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Hyperion DeFi, Inc. (HYPD) is a biotechnology company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported HYPD revenue for 2024-12-31 was $57.3K. Net income was -$49.8M. Revenue was up 1414.0% from 2023-12-31 to 2024-12-31. HYPD currently screens at market cap $48.5M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
HYPD currently screens at market cap $48.5M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the HYPD and REGN stock pages for the full models.
Not investment advice.